Business · 11/01/2023Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Cardiovascular and Renal Drugs Advisory Committee Renewal
Summary
The US Food and Drug Administration is correcting a notice that announced the renewal of the Cardiovascular and Renal Drugs Advisory Committee, which was published with an incorrect docket number in the Federal Register on December 13, 2022.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →